German biotech firm Evotec said it paid $4 million to India-based DIL to complete the acquisition of 70% stake in Research Support International, a drug-discovery and development firm. The deal will allow Evotec to incorporate India's Research Support into its operations in the U.K., Singapore and Germany.

Full Story:

Related Summaries